Minimally Invasive MR Interventional Center (MIMRIC)

My research has focused on rare, monogenetic skin diseases such as Epidermolysis Bullosa (EB) and Gorlin Syndrome (Basal Cell Nevus Syndrome). With my PhD training in basic science, post-doctoral fellowship in clinical research, and residency in dermatology, I am committed to improving the lives of EB patients, to correct their underlying genetic disease and to offer new treatments for their skin and esophageal wounds. I was the PI of the investigator-initiated, Phase 1/2A clinical trial of autologous gene-therapy skin grafts for RDEB (Pz-cel, EB-101, previously called LEAES).

Dr. R. Peter Lokken, MD, MPH, is a notable establishment nestled in the vibrant city of San Francisco, CA. Renowned for its commitment to excellence, this institution stands as a beacon of healthcare in the community. With a dedication to providing top-tier medical services, Dr. R. Peter Lokken, MD, MPH, embodies the values of compassion and expertise. Situated within the bustling urban landscape of San Francisco, this institution upholds a tradition of delivering exceptional care to its patients. Generated using this brand's available information

UCSF Health is internationally renowned for providing patients with specialized and innovative medical care. We support our community's health with hospitals and clinics in San Francisco as well as a regional network of clinics and outpatient centers. Consistently ranked among the nation's best hospitals, UCSF is particularly recognized for excellence in neurology and neurosurgery; cancer care; heart care; diabetes; ear, nose and throat care; and psychiatry and psychology, among other services. We are part of the University of California, San Francisco, one of the nation’s top universities for health sciences research and higher education.